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Plato ver. 14.1.3, and then optimised by
internal algorithm for active source length
of 10 cm (21 step positions) and reference
depths of 5, 7 and 10 mm. TLD chips L1F
100 were used as the detectors after
calibration in Co-60 photon beam and
Harshaw 3500 as a reader. The catheter
and TLD chips were placed in a wax-
parafin phantom assuring the distance
from the catheter to detectors equal to the
reference depth (5, 7 and 10 mm). The
measurements were preformed twice for
every depth - for the non optimised
treatment plan and for the plan with
optimisation algorithm applied. The dose
delivered at the reference distance was
10 Gy.
Results. The treatment plan was
calculated for the active source length
(ASL) of 10 cm. The RIL values calculated
without optimisation of the step times,
were: 8.9 cm, 9.28 cm and 8.96 cm.
The measured RIL were: 8.64 cm, 9.6 cm,
8.32 cm (+/- 0.32 cm), for the RD = 5, 7
and 10 cm, respectively. For the optimised
treatment plan, the calculated RIL were:
10.24 cm, 10.56 cm and 10.56 cm while
the measured RIL were 10.24 cm,
10.56 cm and 9.92 cm (+/- 0.32 cm),
for the RD = 5, 7 and 10 cm, respectively.
The RIL measured during the treatment
carried according to the optimised plan
were by 1.60 cm, 0.96 cm and 1.60 cm
longer then those for the treatment made
without optimisation at the reference
depths. The increase of the dose
measured at the last distal and proximal
position of the application were 35, 38 and
37% for RD = 5, 7 and 10 cm,
respectively.
Conclusion. Optimisation of the
treatment plan is the main tool for the
accurate trealment delivery in
endovascular brachytherapy. The TLD
dosimeters showed the increase of the
dose at distal and proximal parts of the
active length (AL), and thus optimisation
algorithm built in Plato ver. 14.1.3 has
been proven to be correct for the above
clinical situation.
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161.
THE FREQUENT AND PRECISE
MONITORING OF MUCOSAL
REACTION DURING RADIATION
THERAPY IN HEAD AND NECK
CANCER PATIENTS AFFORDS
POSSIBILITIES OF QUANTITATIVE
REPORTING AND PREDICTING ITS
SEVERITY
WygodaA.
I Radiotherapy Clinic, Centre of Oncology
- MSC Memorial Institute in Gliwice
Background. Numerous prospective
clinical studies on acute radiation mucosal
toxicity have been doing over the last 10
years in Gliwice Oncology Centre.
Consequence of those experiences is the
policy of detailed monitoring and reporting
of many objective and sUbjective
symptoms estimating the incidence and
pattern of radiation mucositis.
Aim. To evaluate clinical and treatment-
related factors influencing on duration of
healing, incidence and severity of
mucositis and overall duration of acute
mucosal reaction.
Material and Methods. The unique data
set of careful and frequent observations of
mucosal radiation reaction in 88 con-
secutive patients (pts) with head and neck
cancer treated by radiation alone have
been included into the analysis. There
were 35 pts treated by conventional
fractionation with 2.0Gy per fraction and 4
pts with 2.5Gy per fraction (CF), 33 pts
treated by accelerated fractionation
(CAIR), 8 pts by hyperfractionation (HF),
and 8 pts· with glottic T1 cancer treated by
hypofractionation of 3Gy per day (hF). All
patients have been observed everyday
with examination of oral cavity, pharynx
and larynx done 3 times weekly, by the
same, well experienced radiation
oncologist, according to the own scoring
system based on the Dische' suggestions.
The monitoring of mucosal reaction has
been always beginning at the 1st day of
treatment, before radiation fraction,
followed after the end of treatment, up to
the disappearance of any symptom
(except xerostomia), what was identified
as a complete healing of mucosa.
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Results. Radiation mucositis at least of
the grade 2 (patchy stage) has been
observed in all (100%) pts, usually
beginning from the 11th day (range: 6-21).
The confluent mucositis (grade 3) has
noted in 87 pts (98%) with the median
onset at 14th day (range: 6-39). Reaction
of grade 4 (confluent mucositis occupying
more than 50% of radiated mucosal area -
CME>50) has been detected. in 71 pts
(81%) with the median appearance at 21st
day (range: 9-42), remaining usually 24
days (range: 2-45) notwithstanding below
or equal 7 days in 15 pts (21%).
The incidence and duration of CME>50
has correlated significantly with the type of
fractionation - 88% of pts treated by AF
and HF developed CME>50 which took
about 28 days, compare respectively to
77% of pts and 19 days for CF. Also the
site of CME>50 origin (oral cavity+pharynx
vs. larynx+hypopharynx) was connected
significantly with its incidence and duration
- 25th vs. 20th day and 25 days vs. 19
days, respectively. The most important
factors associated directly with the time of
mucosal healing were duration of
mucositis and its supportive treatment,
maximal total score, accumulated radiation
dose (ADR), area of boost fields and total
radiation dose, but adversely - onset of
dysphagia and onset of mucosal oedema.
The overall duration of mucosal reaction
(i.e. time from the first day of irradiation up
to its complete healing) was significantly
connected directly with duration of
mucositis and its supportive treatment,
areas of radiation fields (initial, shrinking
and boost), total dose, overall radiation
treatment time (ORTT) and maximal total
score, but adversely with site of reaction
origin and with ARD. Finally, the prediction
models of severa.l mucosal reaction end-
points have been created on the base of
multiple regression function. The
increasing number of symptoms
(variables) collecting as the monitoring
progressed has improved the fit of
prediction model for crucial end-points, like
duration of mucosal healing, overall
duration of mucosal reaction, duration of
CME>50 and maximal total score.
The highest adjusted goodness-of-fit
values (adR2) for prediction models
estimated at the end of radiation treatment
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have reached at best to 0.75 (usually were
-0.5), what could meant at least 50%
variability of that reaction depends on
individual radiosensitivity of mucosal
membrane.
Conclusions. 1. High rate of mucositis
grade 4 during conventional fractionation,
reaching 75%, has been in contrast with
general opinion of its lower, 25% rate.
Methodology of this study and relatively
high proportion of patients (-20%), who
experienced such a grade within a very
short time (up to 7 days), suggests
however, that literature data could be
underestimated. 2. In spite of noted, well-
known tendency that AF has prolonged the
time of mucosal healing (on 7 days); the
overall duration of mucosal reaction has
been adversely influenced by ORTT and
ARD, what has given per saldo 1 week
shorter reaction for AF. It suggests that
radiation-free weekends during CF are not
thus important for mucosal healing like it
has believed. The overall duration of
mucosal healing in 5 fractions per week
treatment is longer than for 7 fractions per
week, provided that ARD does not exceed
12.6Gy per week and radiation fields
delivered during the weekends are
relatively small. 3. Frequent and careful
monitoring of the whole course of radiation
mucosal reaction seems to be essential for
individual prediction of its severity and
healing. This procedure claims to be
clinically useful especially for aggressive
altered fractionation or concomitant
chemo-radiotherapy, Le. for those
therapeutic methods where traditional
reporting on radiation mucosal toxicity has
been neglected.
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IS INTENSITY MODULATION
USEFUL IN RADIOSURGERY?
AN ANALYSIS OF CLINICAL
APPLICATIONS OF IMRS
Blamek S., Ficek K., Tarnawski R.,
Miszczyk L.
Centre of Oncology, Maria Siodowska-Curie
Memorial Institute, Radiotherapy Department
Introduction. Treatment modalities
based on single fraction delivery demand
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